The company was also indicted on charges of illegal trade, and the unlawful collection of personal information, AstraZeneca said in its latest financial results this week, though it said no illegal gain was alleged from that. It will not face the more serious charge of insurance fraud.
Chinese authorities have been investigating some of Astra’s current and former employees over alleged law breaches around drug imports, data privacy and insurance ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
